Skip to main content

Cellaïon is a Belgian biotech company developing Life saving advanced therapies to repair tissues and regenerate the liver, Cellaïon targets life threatening diseases.

We are located in the biotech valley of the Walloon region in Belgium.

We are a team of biotech entrepreneurs, physicians and highly talented scientists in the field of liver diseases and cell based regenerative medicine.

Our strong IP base is issued from our own research and the academic research at UCLouvain, developed with the objective to generate new products.

Our lead product HepaStem® is in advanced clinical development in Acute on Chronic Liver Failure (ACLF), a life threatening condition affecting more than 100,000 patients worldwide each year, with a 50% mortality.